An emerging frontier in addiction medicine
Addiction is a complex neurobiological disease characterized by compulsive substance use despite harmful consequences. Standard treatments — including pharmacotherapy, behavioural therapy, and 12-step programs — are effective for many but leave a substantial proportion of patients cycling through relapse.
Emerging research suggests that ketamine, particularly when combined with structured psychotherapy, can meaningfully extend periods of abstinence and reduce craving intensity in addiction. The mechanism involves both neurobiological and psychological dimensions — and its therapeutic potential in this space is generating significant scientific attention.
It is important to note that ketamine for addiction is among the more exploratory of its clinical applications. Candidacy is assessed carefully, and it is not appropriate for individuals with active polysubstance use or current ketamine misuse.
Careful addiction-specific clinical evaluation — candidacy is selective
Full substance use history, current use assessment, and medical screening
Coordination with addiction medicine, psychiatry, or counselling support
Structured integration therapy before and after infusions is essential
Abstinence monitoring and regular follow-up
Clear discussion of what ketamine can and cannot offer in this context